John M. Goldman
John M. Goldman (30 November 1938 – 24 December 2013) was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. He was also a prolific author of scientific papers, was involved with numerous medical charities and had a decades-long surgical career at Hammersmith Hospital, London. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'John M. Goldman', query time: 0.04s
Refine Results
-
1
Chronic myeloid leukemia: the basis of treatment for tomorrow by Angelo M. Carella, John M. Goldman, Giovanni Martinelli, Junia V. Melo, Danilo Perrotti
Published 2011-12-01
Article -
2
-
3
Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? by Sergio Querol, Ghulam J. Mufti, Steven G.E. Marsh, Antonio Pagliuca, Ann-Margaret Little, Bronwen E. Shaw, Robert Jeffery, Joan Garcia, John M. Goldman, J. Alejandro Madrigal
Published 2009-04-01
Article -
4
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms by Tariq I. Mughal, Alessandro M. Vannucchi, Simona Soverini, Alexandra Bazeos, Raoul Tibes, Giuseppe Saglio, Omar Abdel-Wahab, Animesh Pardanani, Rudiger Hehlmann, Tiziano Barbui, Richard Van Etten, Ayalew Tefferi, John M. Goldman
Published 2014-05-01
Article -
5
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia by Dragana Milojkovic, Emma Nicholson, Jane F. Apperley, Tessa L. Holyoake, Pat Shepherd, Mark W. Drummond, Richard Szydlo, Marco Bua, Letizia Foroni, Alistair Reid, Jamshid S. Khorashad, Hugues de Lavallade, Katy Rezvani, Christos Paliompeis, John M. Goldman, David Marin
Published 2010-02-01
Article -
6
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host by Hugues de Lavallade, Paula Garland, Takuya Sekine, Katja Hoschler, David Marin, Kate Stringaris, Eva Loucaides, Katherine Howe, Richard Szydlo, Ed Kanfer, Donald Macdonald, Peter Kelleher, Nichola Cooper, Ahmad Khoder, Ian H. Gabriel, Dragana Milojkovic, Jiri Pavlu, John M. Goldman, Jane F. Apperley, Katayoun Rezvani
Published 2011-02-01
Article